Abstract

Purpose. To identify pathological characteristics of prostate cancer according to patient age at diagnosis. Methods. A retrospective review of 2,929 men diagnosed with prostate cancer was performed. Pathological characteristics were compared across age groups: ≤55, 56–75, and >75 years. Results. The study cohort included 133 patients (4.5%), 2,033 patients (69.5%), and 763 patients (26.0%) in the three age groups, respectively. The median pathological Gleason sums in the three age groups were 8, 7, and 8, respectively. The Gleason sum, primary Gleason score, and second primary Gleason score were significantly different among the three age groups (Z = 12.975, p = 0.002; Z = 9.264, p = 0.010; Z = 6.692, p = 0.035, resp.). The percentages of Gleason pattern 5 tumors for the three age groups were 44.4%, 32.3%, and 36.8%, respectively; they were significantly different (χ2 = 11.641, p = 0.003). The percentages of tumors with Gleason score grade groups 3–5 for the three age groups were 66.9%, 60.5%, and 66.3%, respectively; they were significantly different (χ2 = 9.401, p = 0.009). Conclusions. The present study indicated that men aged ≤55 years or >75 years show higher levels of clinically significant prostate cancer compared to patients between the ages of 55 and 75 years. Younger and more elderly male patients are more likely to have a more aggressive disease.

Highlights

  • Prostate cancer is considered a disease of older men and is infrequently reported in patients aged 55 years or younger [1]

  • Radical prostatectomy is recommended as the standard treatment modality for early stage prostate cancer in men aged 75 years or younger with a life expectancy of more than 10 years [4, 5]

  • After further comparisons performed between Groups 1 and 2 and Groups 2 and 3, it was found that Gleason sum, primary Gleason score, and second primary Gleason score were significantly higher in Group 3 than in Group 2 (p < 0.025)

Read more

Summary

Introduction

Prostate cancer is considered a disease of older men and is infrequently reported in patients aged 55 years or younger [1]. Presently over 10% of new cases of prostate cancer in the US occur in men aged 55 years or younger [2]. Compared with those in older men, the pathological characteristics of prostate cancer in patients 55 years or younger appear to be significantly different [3]. Radical prostatectomy is recommended as the standard treatment modality for early stage prostate cancer in men aged 75 years or younger with a life expectancy of more than 10 years [4, 5]. The pathological features of prostate cancer in elderly patients are different from those of other age cohorts

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call